SABCS 2021 Conference Coverage on VuMedi
SABCS 2021 Update on Samuraciclib, a First-in-Class, Oral, Selective Inhibitor of CDK7, in Combination With Fulvestrant in Advanced HR+/HER2- BC
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Charles Coombes
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Charles Coombes
Login to view comments.
Click here to Login
Videos